ID: ALA4544681

Max Phase: Preclinical

Molecular Formula: C53H68ClN9O12S

Molecular Weight: 1090.70

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1

Standard InChI:  InChI=1S/C53H68ClN9O12S/c1-33(2)75-44-30-38(35(5)29-42(44)59-53-57-31-39(54)49(61-53)58-40-10-6-7-12-45(40)76(69,70)34(3)4)36-15-19-62(20-16-36)32-47(65)56-18-22-72-24-26-74-28-27-73-25-23-71-21-17-55-41-11-8-9-37-48(41)52(68)63(51(37)67)43-13-14-46(64)60-50(43)66/h6-12,29-31,33-34,36,43,55H,13-28,32H2,1-5H3,(H,56,65)(H,60,64,66)(H2,57,58,59,61)

Standard InChI Key:  QTBMHRVZWBBKIB-UHFFFAOYSA-N

Associated Targets(Human)

SU-DHL-1 173 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/ALK 13 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1090.70Molecular Weight (Monoisotopic): 1089.4397AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Kargbo RB..  (2019)  PROTACs and Targeted Protein Degradation for Treating ALK-Mediated Cancers.,  10  (8): [PMID:31413792] [10.1021/acsmedchemlett.9b00296]

Source